banner about

Dr. René Vleugels


Received a MA in Economics (University of Texas at Austin, 1984) and completed a PhD study at the Radbout University Nijmegen (Policy Sciences, 1990). He worked for the World Bank in Mexico (1985). He then worked as TTO for the Life Sciences departments of the Maastricht University, and was senior executive of the Maastricht University Holding. In 1996 he founded MUbio Products BV with prof. dr Frans Ramaekers (monoclonal antibodies for cancer research) where he was managing director till 2010. In 2000 he founded NovoVacs BV (vaccine technology), which merged with MUbio in 2006. In 2010 he worked as consultant in Life Sciences. In 2011 he founded CyTuVax with prof. dr Frank Falkenberg.




Latest news

showCyTuVax is currently testing its vaccine technology in a clinical Phase 2 study of a vaccine for hepatitis B non-responders

Where we are

About us

CyTuVax B.V.
Oxfordlaan 55
6229 EV Maastricht
The Netherlands

This email address is being protected from spambots. You need JavaScript enabled to view it.